ADMA Biologics Statistics Share Statistics ADMA Biologics has 238.63M
shares outstanding. The number of shares has increased by 2.42%
in one year.
Shares Outstanding 238.63M Shares Change (YoY) 2.42% Shares Change (QoQ) 0.47% Owned by Institutions (%) 86.01% Shares Floating 230.44M Failed to Deliver (FTD) Shares 282 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 14.47M, so 6.06% of the outstanding
shares have been sold short.
Short Interest 14.47M Short % of Shares Out 6.06% Short % of Float 7.44% Short Ratio (days to cover) 7.38
Valuation Ratios The PE ratio is 20.22 and the forward
PE ratio is 18.36.
ADMA Biologics's PEG ratio is
-0.03.
PE Ratio 20.22 Forward PE 18.36 PS Ratio 9.37 Forward PS 6.2 PB Ratio 11.45 P/FCF Ratio 36.31 PEG Ratio -0.03
Financial Ratio History Enterprise Valuation ADMA Biologics has an Enterprise Value (EV) of 3.98B.
EV / Sales 9.32 EV / EBITDA 26.92 EV / EBIT 33.51 EV / FCF 36.12
Financial Position The company has a current ratio of 5.97,
with a Debt / Equity ratio of 0.24.
Current Ratio 5.97 Quick Ratio 2.9 Debt / Equity 0.24 Debt / EBITDA 0.56 Debt / FCF 0.75 Interest Coverage 9.98
Financial Efficiency Return on Equity is 56.64% and Return on Invested Capital is 50.31%.
Return on Equity 56.64% Return on Assets 40.45% Return on Invested Capital 50.31% Revenue Per Employee $622.56K Profits Per Employee $288.57K Employee Count 685 Asset Turnover 0.87 Inventory Turnover 1.22
Taxes Income Tax -71.96M Effective Tax Rate -57.24%
Stock Price Statistics The stock price has increased by -0.24% in the
last 52 weeks. The beta is 0.38, so ADMA Biologics's
price volatility has been higher than the market average.
Beta 0.38 52-Week Price Change -0.24% 50-Day Moving Average 18.7 200-Day Moving Average 18.77 Relative Strength Index (RSI) 36.33 Average Volume (20 Days) 3,053,082
Income Statement In the last 12 months, ADMA Biologics had revenue of 426.45M
and earned 197.67M
in profits. Earnings per share was 0.85.
Revenue 426.45M Gross Profit 219.55M Operating Income 138.98M Net Income 197.67M EBITDA 147.69M EBIT 139.64M Earnings Per Share (EPS) 0.85
Full Income Statement Balance Sheet The company has 103.15M in cash and 82.12M in
debt, giving a net cash position of 21.03M.
Cash & Cash Equivalents 103.15M Total Debt 82.12M Net Cash 21.03M Retained Earnings -308.58M Total Assets 558.38M Working Capital 324.62M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 118.67M
and capital expenditures -8.57M, giving a free cash flow of 110.1M.
Operating Cash Flow 118.67M Capital Expenditures -8.57M Free Cash Flow 110.1M FCF Per Share 0.47
Full Cash Flow Statement Margins Gross margin is 51.48%, with operating and profit margins of 32.59% and 46.35%.
Gross Margin 51.48% Operating Margin 32.59% Pretax Margin 29.48% Profit Margin 46.35% EBITDA Margin 34.63% EBIT Margin 32.59% FCF Margin 25.82%
